Histogen (HSTO) Stock Price, News & Analysis
Company Description
Histogen (OTC: HSTO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
HSTO stock has declined 33.9% over the past year. Shares last traded at $0.2100.
This page provides a comprehensive overview of HSTO stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Histogen (HSTO) stock last traded at $0.2100. Over the past 12 months, the stock has lost 33.9%.
Latest News
Histogen has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings. View all HSTO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HSTO Company Profile & Sector Positioning
Histogen (HSTO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.